Knockdown of β‑catenin by siRNA influences proliferation, apoptosis and invasion of the colon cancer cell line SW480
- Authors:
- Kui Li
- Zhong‑Yin Zhou
- Pan‑Pan Ji
- He‑Sheng Luo
View Affiliations
Affiliations: Department of Gastroenterology, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, P.R. China
- Published online on: April 20, 2016 https://doi.org/10.3892/ol.2016.4481
-
Pages:
3896-3900
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The aim of the present study was to explore the effect of knocking down the expression of β‑catenin by small interference (si)RNA on the activity of the Wnt/β‑catenin signaling pathway, and the proliferation, apoptosis and invasion abilities of the human colon cancer cell line SW480. For that purpose, double‑stranded siRNA targeting β‑catenin (β‑catenin‑siRNA) was synthesized and transfected into SW480 cells. Reverse transcription‑polymerase chain reaction (RT‑PCR) and western blotting were used to detect the messenger (m)RNA and protein levels of β‑catenin in SW480 cells. To detect cell proliferation, 3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide assay was performed, while cell apoptosis and caspase‑3 activity were detected by flow cytometry and caspase‑3 activity assay, respectively. Matrigel invasion assay was performed to detect the influence of siRNA‑mediated gene silencing on the invasion and metastasis of SW480 cells in vitro. The results of RT‑PCR and western blot analysis demonstrated that, compared with the blank control, negative control and liposome groups, β‑catenin‑siRNA transfected SW480 cells had significantly decreased mRNA and protein levels of β‑catenin. In addition, following β‑catenin‑siRNA transfection, the proliferation of SW480 cells was significantly lower than that of the blank control, negative control and liposome groups, while the apoptosis rate increased in β‑catenin‑siRNA transfected cells, compared with the aforementioned groups. Invasion assay showed that, following β‑catenin‑siRNA transfection, the number of SW480 cells infiltrating through the Matrigel membrane was significantly lower than that of the blank control, negative control and liposome groups. Following β‑catenin‑siRNA transfection, the caspase‑3 activity in SW480 cells was lower than that in the blank control, negative control and liposome groups. These results indicate that siRNA‑mediated silencing of β‑catenin could inhibit the proliferation and invasion of SW480 cells and induce apoptosis, thus providing novel potential strategies for the clinical treatment of colon cancer, and may serve as a novel target for cancer therapy.
View References
|
1
|
Fodde R and Brabletz T: Wnt/beta-catenin
signaling in cancer stemness and malignant behavior. Curr Opin Cell
Biol. 19:150–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ring A, Kim YM and Kahn M: Wnt/catenin
signaling in adult stem cell physiology and disease. Stem Cell Rev.
10:512–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan K, Li N, Qi J, Yin P, Zhao C, Wang L,
Li Z and Zha X: Wnt/β-catenin signaling induces the transcription
of cystathionine-γ-lyase, a stimulator of tumor in colon cancer.
Cell Signal. 26:2801–2808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lazarova DL, Wong T, Chiaro C, Drago E and
Bordonaro M: p300 influences butyrate-mediated WNT hyperactivation
in colorectal cancer cells. J Cancer. 4:491–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumawat K, Koopmans T and Gosens R:
β-catenin as a regulator and therapeutic target for asthmatic
airway remodeling. Expert Opin Ther Targets. 18:1023–1034. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Denais C and Lammerding J: Nuclear
mechanics in cancer. Adv Exp Med Biol. 773:435–470. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tan CW, Gardiner BS, Hirokawa Y, Layton
MJ, Smith DW and Burgess AW: Wnt signalling pathway parameters for
mammalian cells. PLoS One. 7:e318822012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paul S and Dey A: Wnt signaling and cancer
development: Therapeutic implication. Neoplasma. 55:165–176.
2008.PubMed/NCBI
|
|
9
|
Lai T, Su C, Kuo W, Yeh Y, Kuo W, Tsai F,
Tsai C, Weng Y and Huang C: β-catenin plays a key role in
metastasis of human hepatocellular carcinoma. Oncology Reports.
26:415–422. 2011.PubMed/NCBI
|
|
10
|
Voronkov A and Krauss S: Wnt/beta-catenin
signaling and small molecule inhibitors. Curr Pharm Des.
19:634–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmeel LC, Schmeel FC, Kim Y, Endo T, Lu
D and Schmidt-Wolf IG: Targeting the Wnt/beta-catenin pathway in
multiple myeloma. Anticancer Res. 33:4719–4726. 2013.PubMed/NCBI
|
|
13
|
Yao H, Ashihara E and Maekawa T: Targeting
the Wnt/β-catenin signaling pathway in human cancers. Expert Opin
Ther Targets. 15:873–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Behrens J: Control of beta-catenin
signaling in tumor development. Ann N Y Acad Sci. 910:21–35. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Flemr M, Malik R, Franke V, Nejepinska J,
Sedlacek R, Vlahovicek K and Svoboda P: A retrotransposon-driven
dicer isoform directs endogenous small interfering RNA production
in mouse oocytes. Cell. 155:807–816. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dogini DB, Pascoal VD, Avansini SH, Vieira
AS, Pereira TC and Lopes-Cendes I: The new world of RNAs. Genet Mol
Biol. 37(Suppl 1): S285–S293. 2014. View Article : Google Scholar
|
|
17
|
Fellmann C and Lowe SW: Stable RNA
interference rules for silencing. Nat Cell Biol. 16:10–18. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ismail B, Ghezali L, Gueye R, Limami Y,
Pouget C, Leger DY, Martin F, Beneytout J, Duroux J, Diab-Assaf M,
et al: Novel methylsulfonyl chalcones as potential
antiproliferative drugs for human prostate cancer: Involvement of
the intrinsic pathway of apoptosis. Int J Oncol. 43:1160–1168.
2013.PubMed/NCBI
|
